Multi-target brokers are widespread in drug discovery and promiscuous multi-kinase inhibitors have proved therapeutically powerful anticancer drugs; using this for instance, we propose that E7449 might have greater or broader therapeutic success by its dual PARP/TNKS inhibition. Autophagy stimulation by rapamycin suppresses lung inflammation and an infection by Burkholderiacenocepacia... https://harryw000skc1.wikilinksnews.com/user